Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAL056 in Postmenopausal Women With Osteoporosis
NCT07579936Phase 2Recruiting
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Apr 2026
- Primary completion
- Jul 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Xinfutai in osteoporosis, sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Apr 2026; status: recruiting.
02
Drugs
Xinfutai
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07579936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07579936.